Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengkai Lu

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Drug Design, Development and Therapy|June 9, 2026
<i>Astragaloside</i> IV in Combination with <i>Tanshinone</i> IIA Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting CTR1/ATOX1/LOX Axis-Mediated Collagen Cross-Linking in MyofibroblastsHongqin Wang, Mengkai Lu, Yuan Li, et al.
Phytotherapy Research : PTR|June 17, 2024
Notoginsenoside R<sub>1</sub> decreases intraplaque neovascularization by governing pericyte-endothelial cell communication via Ang1/Tie2 axis in atherosclerosisYuan Li, Lei Zhang, Wenqing Yang, et al.
The Journal of Nutritional Biochemistry|November 20, 2023
Advances in the study of vascular related protective effect of garlic (Allium sativum) extract and compoundsMengkai Lu, Jinyuan Pan, Yuanlong Hu, et al.
Experimental Gerontology|March 25, 2026
Association of Dietary Inflammatory Index (DII) with cardiovascular and all-cause mortality in patients with Cardiovascular-Kidney-Metabolic (CKM) syndrome: a prospective cohort studyRui Sun, Xintong Li, Xinhai Cui, et al.
American Journal of Preventive Cardiology|September 22, 2025
Contribution of high BMI to the global burden of cardiovascular disease among young adults aged 20-39 from 1990 to 2021: A systematic analysis for the Global burden of disease study 2021Jiaqi Hao, Mengkai Lu, Rui Sun, et al.
International Immunopharmacology|November 9, 2024
Notoginsenoside R1-Protocatechuic aldehyde reduces vascular inflammation and calcification through increasing the release of nitric oxide to inhibit TGFβR1-YAP/TAZ pathway in vascular smooth muscle cellsXinhai Cui, Lei Zhang, Lin Lin, et al.
British Journal of Pharmacology|March 31, 2025
Rhynchophylline as an agonist of sirtuin 3 ameliorates endothelial dysfunction via antagonizing mitochondrial damage of endothelial progenitor cellsLin Lin, Bowen Sun, Yuanlong Hu, et al.
Mayo Clinic Proceedings|February 7, 2025
Body Fat Distribution and Ectopic Fat Accumulation as Mediator of Diabetogenic Action of Lipid-Modifying Drugs: A Mediation Mendelian Randomization StudyYuanlong Hu, Xinhai Cui, Mengkai Lu, et al.
Hypertension (Dallas, Tex. : 1979)|March 15, 2024
Identification of Circulating Plasma Proteins as a Mediator of Hypertension-Driven Cardiac Remodeling: A Mediation Mendelian Randomization StudyYuanlong Hu, Lin Lin, Lei Zhang, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Drug Design, Development and Therapy|June 9, 2026
<i>Astragaloside</i> IV in Combination with <i>Tanshinone</i> IIA Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting CTR1/ATOX1/LOX Axis-Mediated Collagen Cross-Linking in MyofibroblastsHongqin Wang, Mengkai Lu, Yuan Li, et al.
Phytotherapy Research : PTR|June 17, 2024
Notoginsenoside R<sub>1</sub> decreases intraplaque neovascularization by governing pericyte-endothelial cell communication via Ang1/Tie2 axis in atherosclerosisYuan Li, Lei Zhang, Wenqing Yang, et al.
The Journal of Nutritional Biochemistry|November 20, 2023
Advances in the study of vascular related protective effect of garlic (Allium sativum) extract and compoundsMengkai Lu, Jinyuan Pan, Yuanlong Hu, et al.
Experimental Gerontology|March 25, 2026
Association of Dietary Inflammatory Index (DII) with cardiovascular and all-cause mortality in patients with Cardiovascular-Kidney-Metabolic (CKM) syndrome: a prospective cohort studyRui Sun, Xintong Li, Xinhai Cui, et al.
American Journal of Preventive Cardiology|September 22, 2025
Contribution of high BMI to the global burden of cardiovascular disease among young adults aged 20-39 from 1990 to 2021: A systematic analysis for the Global burden of disease study 2021Jiaqi Hao, Mengkai Lu, Rui Sun, et al.
International Immunopharmacology|November 9, 2024
Notoginsenoside R1-Protocatechuic aldehyde reduces vascular inflammation and calcification through increasing the release of nitric oxide to inhibit TGFβR1-YAP/TAZ pathway in vascular smooth muscle cellsXinhai Cui, Lei Zhang, Lin Lin, et al.
British Journal of Pharmacology|March 31, 2025
Rhynchophylline as an agonist of sirtuin 3 ameliorates endothelial dysfunction via antagonizing mitochondrial damage of endothelial progenitor cellsLin Lin, Bowen Sun, Yuanlong Hu, et al.
Mayo Clinic Proceedings|February 7, 2025
Body Fat Distribution and Ectopic Fat Accumulation as Mediator of Diabetogenic Action of Lipid-Modifying Drugs: A Mediation Mendelian Randomization StudyYuanlong Hu, Xinhai Cui, Mengkai Lu, et al.
Hypertension (Dallas, Tex. : 1979)|March 15, 2024
Identification of Circulating Plasma Proteins as a Mediator of Hypertension-Driven Cardiac Remodeling: A Mediation Mendelian Randomization StudyYuanlong Hu, Lin Lin, Lei Zhang, et al.
Pageof 3